As confirmed by the drug manufacturer on Monday, the US Food and Drug Administration has delayed its approval status on Cephalon Inc's medicine Nuvigil, which has now been seeking approval to treat constant sleepiness caused by jet lag. The decision has been push forward by 3 months.